Capital International Investors
BMRN icon

Capital International Investors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Capital International Investors’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,864
Closed -$344K – 456
2021
Q4 		$344K Sell
3,864
-543,937
-99% -$44.9M ﹤0.01% 457
2021
Q3 		$42.3M Sell
547,801
-242
-0% -$19.1K 0.01% 362
2021
Q2 		$45.7M Buy
548,043
+1,102
+0.2% +$87.4K 0.01% 366
2021
Q1 		$41.3M Buy
546,941
+280
+0.1% +$22.9K 0.01% 353
2020
Q4 		$47.9M Buy
546,661
+936
+0.2% +$74.2K 0.01% 335
2020
Q3 		$41.5M Sell
545,725
-429,601
-44% -$43.5M 0.01% 327
2020
Q2 		$120M Buy
975,326
+1,797
+0.2% +$179K 0.04% 242
2020
Q1 		$82.3M Sell
973,529
-1,593,708
-62% -$137M 0.03% 228
2019
Q4 		$217M Buy
2,567,237
+1,454
+0.1% +$110K 0.07% 185
2019
Q3 		$173M Buy
2,565,783
+764,300
+42% +$58.9M 0.07% 194
2019
Q2 		$154M Buy
1,801,483
+24,664
+1% +$2.11M 0.06% 208
2019
Q1 		$158M Sell
1,776,819
-1,635,825
-48% -$152M 0.07% 196
2018
Q4 		$291M Buy
3,412,644
+1,308,641
+62% +$124M 0.14% 150
2018
Q3 		$204M Buy
+2,104,003
New +$210M 0.09% 179

Other funds holding BMRN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Capital International Investors's BMRN Position: Q1 2022 in Review

Capital International Investors sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2022, closing a stake of 3,864 shares — an estimated $344K sold.

Capital International Investors first reported a position in BMRN in Q3 2018 and held it in 14 quarters. The position peaked at $291M in Q4 2018. 561 funds tracked by Wall St. Rank hold BMRN as of Q1 2022.

  • Capital International Investors reported no remaining BioMarin Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Capital International Investors sold 3,864 BioMarin Pharmaceuticals shares in Q1 2022, an estimated $344K.
  • Capital International Investors first reported a position in BioMarin Pharmaceuticals in Q3 2018 and held it in 14 quarters.
  • Capital International Investors's BioMarin Pharmaceuticals position peaked at $291M in Q4 2018.
  • 561 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2022.

Based on Capital International Investors's 13F filing for Q1 2022, filed 16 May 2022.